Efficacy of first-line levofloxacin-based therapy for Helicobacter pylori eradication. Results from a single tertiary center cohort in Argentina
Abstract
BACKGROUND AND OBJECTIVE
Helicobacter pylori (H. pylori) colonizes the gastric mucosa in approximately half of the global population and is a well-established risk factor for peptic ulcer disease and gastric adenocarcinoma. Data on the effectiveness of levofloxacin-based eradication regimens in Argentina remain scarce. The objective of the study was to evaluate the eradication efficacy of a 14-day levofloxacin-containing triple therapy regimen in treatment-naïve patients with H. pylori infection.
PATIENTS AND METHODS
This single-center retrospective study included treatment-naïve adult patients with histologically confirmed H. pylori infection between 09/2020-07/2023. Patients received a 14-day regimen consisting of amoxicillin 1 g twice daily, levofloxacin 500 mg once daily, and pantoprazole 40 mg twice daily. Eradication was assessed by ¹³C-urea breath test performed at least 4 weeks following treatment completion.
RESULTS
The study included 277 patients (median age 57 years; 60.6% female). The eradication rate was 76.2% evaluated through modified intention to treat analysis. Eradication rates did not differ by age, sex, body mass index, or other baseline clinical characteristics. Treatment-related adverse events occurred in 11 (4%) patients and 6 (2.2%) patients did not complete the prescribed treatment regimen due to adverse events.
CONCLUSION
The 14-day levofloxacin-based triple therapy regimen achieved a suboptimal H. pylori eradication rate, falling below the…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 277 participants or records.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.